Molecular testing in cytology

被引:3
|
作者
Schmitt, Fernando [1 ,3 ]
Yang, Zhongbo [2 ,4 ]
Esebua, Magda [5 ]
机构
[1] Univ Porto, Fac Med, Porto, Portugal
[2] Cintesis RISE, Hlth Res Network, Porto, Portugal
[3] Univ Porto, IPATIMUP, Inst Patol & Imunol Mol, Porto, Portugal
[4] Roswell Pk Comprehens Canc Ctr, Dept Pathol, Buffalo, NY USA
[5] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA
关键词
cytology samples; molecular testing;
D O I
10.1002/dc.25071
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In the era of personalized medicine, molecular testing plays a critical role in patient care. The rapid advance of molecular techniques, especially next-generation sequencing, makes molecular diagnosis feasible in daily practice. Molecular testing can be used as a valuable ancillary test to increase diagnostic sensitivity and specificity, especially in small biopsy or cytology samples. In addition, molecular testing plays an important role in selecting patients for appropriate treatment by detecting therapeutic and predictive biomarkers in tissue or cytology samples. Molecular studies can be applied in all cytology samples, sometimes with better results than histology. As molecular testing has become essential for patient care and is often requested to be performed in cytology samples, it is critical for cytopathologists to understand the basics of molecular diagnostic methods, indications for molecular testing, and how to best utilize different cytologic samples for this purpose. In this special issue, experts in various areas of cytopathology and molecular pathology review the literature and discuss the basics of molecular techniques and the application of molecular testing in various types of cytology samples. It is our hope that after reading the articles in this special issue, the readers can know better about the possibilities of molecular cytology, a very exciting field of pathology.
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [21] Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility
    Ghous, Ghulam
    Ijaz, Komal
    Esebua, Magda
    Layfield, Lester J.
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (02) : 123 - 130
  • [22] Cost-effectiveness of Molecular Testing for Thyroid Nodules With Indeterminate Cytology
    Ahmadi, Sara
    Sipos, Jennifer A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [23] The Cytology Samples and Plasma Specimens were Feasible for the EGFR Molecular Testing
    Ohira, T.
    Hamanaka, W.
    Shimada, Y.
    Maehara, S.
    Maeda, J.
    Hagiwara, M.
    Kakihana, M.
    Okano, T.
    Kajiwara, N.
    Ikeda, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S897 - S897
  • [24] Evaluation of the Suitability of Cytology Fluid Samples for Molecular Testing in Lung Cancer
    Judd, A.
    Broehm, C.
    Chabot-Richards, D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1221 - 1221
  • [25] CYTOLOGY PROFICIENCY TESTING
    KELLY, S
    LABORATORY MEDICINE, 1994, 25 (08) : 535 - 535
  • [26] Testing in cervicovaginal cytology
    Koss, LG
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (01) : 13 - 13
  • [27] The role of cytology specimens in molecular testing of solid tumors: Techniques, limitations, and opportunities
    Aisner, Dara L.
    Sams, Sharon B.
    DIAGNOSTIC CYTOPATHOLOGY, 2012, 40 (06) : 511 - 524
  • [28] Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges
    Canberk, Sule
    Engels, Marianne
    VIRCHOWS ARCHIV, 2021, 478 (01) : 45 - 57
  • [29] The role of cytology in molecular testing and personalized medicine in lung cancer: A clinical perspective
    Young, Kelvin
    Santos, Gilda da Cunha
    Card, Paul
    Leighl, Natasha
    CANCER CYTOPATHOLOGY, 2019, 127 (02) : 72 - 78
  • [30] Utility and cost-effectiveness of molecular testing in thyroid nodules with indeterminate cytology
    Labourier, Emmanuel
    CLINICAL ENDOCRINOLOGY, 2016, 85 (04) : 624 - 631